KMS MEDISURGI LIMITED
Nature of Disclosure:
This is a regulatory intimation to BSE Limited, submitted pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has scheduled a meeting of its Board of Directors.
Key Details:
- The Board meeting is scheduled to be held on Saturday, 5th September, 2026.
- The agenda for the meeting includes the following items to be considered and transacted:
- To consider and approve the day, date, time, and venue for convening the 28th Annual General Meeting (AGM) of the Company.
- To consider and approve the Directors' Report for the financial year ended 31st March, 2026.
- To consider and approve the Notice convening the 28th AGM.
- To recommend the Financial Statements for the financial year ended 31st March, 2026 for consideration and adoption by the members at the ensuing AGM.
- To consider and take on record the Management Discussion and Analysis Report for the financial year ended 31st March, 2026.
- To consider and approve the dates for closure of the Register of Members and Share Transfer Books in connection with the 28th AGM.
- To consider and recommend, if any, the final dividend on the equity shares of the Company for the financial year ended 31st March, 2026.
- To consider and approve the appointment of a Scrutinizer for conducting the voting process at the 28th AGM.
- To consider and transact any other business with the permission of the Chair.
Financial Impact:
A potential financial impact is contingent on the Board's decision to recommend a final dividend. The disclosure states the Board will 'consider and recommend, if any,' indicating a dividend is not guaranteed. The quantum of any potential dividend is not specified.
Parties Involved:
- Regulatory Recipient: BSE Limited